<DOC>
	<DOCNO>NCT00581607</DOCNO>
	<brief_summary>Patients advanced sarcoidosis often develop pulmonary hypertension . Pulmonary hypertension condition right side heart push blood though lung high pressure normal . Since pressure higher , hard heart pump blood lung leave side body . If blood get lung , get pump rest body . This lead weakness shortness breath . This type hypertension usually respond regular blood pressure medicine . The purpose study determine bosentan ( Tracleer ) help sarcoidosis associate pulmonary hypertension .</brief_summary>
	<brief_title>Double Blind , Randomized Trial Bosentan Sarcoidosis Associated Pulmonary Hypertension</brief_title>
	<detailed_description>Patients randomize 2:1 manner receive either bosentan placebo 16 week . After 16 week , additional 32 week open label extension .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Sarcoidosis</mesh_term>
	<mesh_term>Bosentan</mesh_term>
	<criteria>Patients know sarcoidosis 21 . Age 18 great Patients document pulmonary hypertension PA mean &gt; 25 mm Hg measure cardiac catheterization within six month entry study . Pulmonary artery occlude pressure leave ventricular end diastolic pressure must less 15 mm Hg . Patients WHO class II III Six minute walk distance 100 500 meter Patients stable immunotherapy sarcoidosis , include prednisone , methotrexate , azathioprine , hydroxychloroquine , cyclophosphamide , thalidomide , and/or infliximab Patients able provide write consent Patients pulmonary vasodilator drug ( flolan , remodulin , bosentan , sildenafil ) n prior 28 day . Patients stable dose calcium channel blocker 1 month prior right heart catheterization continue calcium channel blocker . Patients severe airway obstruction define FEV1/FVC le 35 % Patients World Health Organization ( WHO ) class IV status . Patients pregnant breast feed Patients significant leave ventricular dysfunction leave ventricular ejection fraction le 35 % Cardiac index &lt; 2.0 liter and/or right atrial pressure &gt; 15 mm Hg Significant liver dysfunction due sarcoidosis . Patients severe organ disease felt investigator impact survival course study . Patients unable perform 6 minute walk study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Sarcoidosis</keyword>
</DOC>